跳到正文
原文
Eric Topol· @EricTopol · X·· 1 天前AI 评分40
AI 导读

向"不可成药"癌症基因进军。近期在胰腺癌RAS靶点上取得重大进展。MYC会是下一个吗? https://www.cell.com/molecular-cell/abstract/S1097-2765(26)00675-1 https://www.nature.com/articles/s41591-024-02805-1 赠阅链接 https://www.nytimes.com/2026/10/02/science/scientists-untangle-the-biology-of-an-undruggable-cancer-gene.html?unlocked_article_code=1.GVE.lU5n.3ei8z5daawkf&smid=url-share

正文

The march against "undruggable" cancer genes. A recent, momentous advance vs RAS in pancreatic cancer. Could MYC be next?
https://www.cell.com/molecular-cell/abstract/S1097-2765(26)00675-1
https://www.nature.com/articles/s41591-024-02805-1
gift link
https://www.nytimes.com/2026/10/02/science/scientists-untangle-the-biology-of-an-undruggable-cancer-gene.html?unlocked_article_code=1.GVE.lU5n.3ei8z5daawkf&smid=url-share

来源:Eric Topol · x.com